Odyssey Marine (OMEX) Gains 169% on Merger News
American Ocean Minerals Corporation to Merge with Odyssey Marine Exploration, Inc., Creating a $1B U.S.-Controlled Deep-Sea Critical Minerals Platform
March 30th: Adding Odyssey Marine (OMEX)...
Institutional Gold Analyst: 2026 Watch List.
The Perfect Timing - for Precious Metals..
Timing is a 'personal' issue, related to short and long-term investor goals, but generally speaking (for long-term investors),...
The Iran War and AI Cyber Threats
Virtually all cyberattacks will be AI-enabled or entirely AI, says Armadin CEO Kevin Mandia
Kevin Mandia, Armadin CEO, joins ‘Squawk Box’ to discuss the cyber...
Sekur Private Data (SWISF) Locked and Loaded.
We Can Feel the Wind Behind Its Back!
Sekur (SWISF) probably has one of the simplest stories we follow. Risky because it is a modestly...
Latest Research Report: $20 Price Target from Greenridge Global.
Here are four research reports below to peruse, all with price targets $20.00 or more...
While we don't issue price targets, it's comforting to see...
AI Data Center Short – Jim Chanos
“If the economic life on these things is three years ... the whole economics of a lot of these deals kind of falls...
Society Pass (SOPA) Perking Up, Gains 169% in Last Trading Five Days.
For the record, we are not traders. And that 'not-something-moniker' dates back to 1995. So while it's nice to see it perking up, we...
What? VYSTAR® Won the Lawsuit? Are you Kidding me?
Vystar® Reports, Following its First of its Kind Court Victory against EMA Financial, Inc. of $497,439.58 in Legal Fees and Costs Awarded.
"Work was strategic,...
Inbcubator Society Pass (SOPA), Expanding into Private AI Software Companies, and Private AI Data...
Society Pass was riding high earlier this year, after announcing they had successfully spun off one of its holding companies NusaTrip (NUTR), into a...
GeoVax (GOVX) Reports Both Favorable Safety and “It’s Working” News for its Cancer...
Official Headline is "GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck...















